Latest news on ‘Health & Drug’
-
Medicare back on the brink over cuts to doctors
WASHINGTON (AP) – Politicians of both parties outdo each other vying for the approval of seniors, but their inability to compromise on the federal budget has put Medicare in the [...]
-
Health Care: Justices to Have Last Word?
Time – (WASHINGTON) — The weight of a Supreme Court decision isn’t likely to settle the contentious debate over health care in America, a nation disdainful of big government and [...]
-
Johnson & Johnson details drug pipeline advances
TRENTON, N.J. (AP) — Johnson & Johnson said Thursday that its growing pharmaceutical business is in a very strong position compared to competitors, with plans to seek approval of 11 [...]
-
Sanofi, Genzyme Boards Said Near to Approving Takeover at About $74-Share
Bloomberg – Sanofi-Aventis SA and Genzyme Corp. are likely to approve a takeover of the U.S. biotechnology company today and are discussing a price of about $74 a share plus [...]
-
Glaxo Takes $3.4 Billion Charge on Legal Problems
The British drug maker, GlaxoSmithKline, announced Monday that it was setting aside $3.4 billion to pay for United States government investigations and for product liability cases over its marketing of [...]
-
Merck falls on drug study woes
MarketWatch — Shares of pharmaceutical giant Merck & Co. fell more than 6% Thursday on news that the company is discontinuing a key clinical trial and modifying a second for [...]
-
J.&J. Unit Issues Recall of Rolaids
NY Times – A unit of Johnson & Johnson announced a nationwide recall on Thursday of all lots — more than 13 million packages — of the soft chewable versions [...]
-
J&J confirms widely expanded contact lens recall
NEW YORK (Reuters) – Johnson & Johnson, which has been beset by product recalls, on Wednesday confirmed that it recalled nearly five times as many contact lenses as the 100,000 [...]
-
U.S. Debt Proposal Would Cut Social Security, Taxes, Medicare
Bloomberg – A presidential commission’s leaders proposed a $3.8 trillion deficit-cutting plan that would cut Social Security and Medicare, reduce income-tax rates and eliminate tax breaks including the mortgage-interest deduction.
The [...] -
P&G Earnings Fall 6.8% Due to Higher Costs
By ANJALI CORDEIRO
Procter & Gamble Co.’s fiscal first-quarter earnings dropped 6.8% as higher commodity costs hurt margins, although sales of such key brands as Pantene and Olay climbed globally.
The decline [...]
